---
title: "Leqvio (inclisiran) in hypercholesterolemia: Indication questions"
description: "Indication questions on Leqvio (inclisiran) in hypercholesterolemia, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Questions: What is Leqvio approved for? 1 question quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/leqvio--hypercholesterolemia/indication"
published: "2026-11-14T00:11:41-05:00"
modified: "2026-11-14T01:54:55-05:00"
---

# Leqvio (inclisiran) in hypercholesterolemia: Indication questions

Manufacturer: Novartis Pharmaceuticals Corporation  
Prescribing information: [Leqvio](https://www.novartis.com/us-en/sites/novartis_us/files/leqvio.pdf)

Indication questions that apply to every indication of Leqvio are on [Leqvio (inclisiran), all indications: Indication](https://www.evicenter.com/medical-information/leqvio/indication).

## Indication

<a id="leqvio-indication"></a>

### What is Leqvio approved for?

> “LEQVIO<sup>®</sup> is indicated as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C) 
> in:  
> • adults with hypercholesterolemia.”

Source: [LEQVIO: Prescribing information, page 2, captured 2026-11-14](https://www.novartis.com/us-en/sites/novartis_us/files/leqvio.pdf#page=2)

Note: The Prescribing Information (revised 08/2026) also lists indications in adults and pediatric patients 12 years and older with heterozygous familial hypercholesterolemia and in pediatric patients 12 years and older with homozygous familial hypercholesterolemia; this page covers the adult hypercholesterolemia indication. The Leqvio HCP site's indication statement, as captured on November 14, 2026, reads "adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia (HeFH)".

## Related pages
- [Medical information: Leqvio (inclisiran): Hypercholesterolemia](https://www.evicenter.com/medical-information/leqvio--hypercholesterolemia)
- [Clinical trials](https://www.evicenter.com/medical-information/leqvio--hypercholesterolemia/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/leqvio--hypercholesterolemia/safety)
- [Specific populations](https://www.evicenter.com/medical-information/leqvio--hypercholesterolemia/specific-populations)
- [Dosing and administration](https://www.evicenter.com/medical-information/leqvio--hypercholesterolemia/dosing-and-administration)
- [Guidelines](https://www.evicenter.com/medical-information/leqvio--hypercholesterolemia/guidelines)
